P15941 (MUC1_HUMAN) Homo sapiens (Human)
Mucin-1 UniProtKBInterProSTRINGInteractive Modelling
1255 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5; Isoform 6; Isoform 7; Isoform 8; Isoform 9; Isoform 10; Isoform 11; Isoform 12; Isoform 13; Isoform 14; Isoform 15; Isoform 16; Isoform 17)
Available Structures
20 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoST) |
Heteromer | 100 | 2×NGA; | |||
| Crystal structure of SN-101 mAb in complex with MUC1 glycopeptide |
Heteromer | 100 | 1×A2G; | |||
| Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) |
Heteromer | 100 | 1×NGA; | |||
| CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE |
Heteromer P01723; P01801; | 100 | 8×CD; 2×CL; | |||
| Crystal structure of the 139H2 Fab fragment bound to Muc1 peptide epitope |
Heteromer | 100 | ||||
| Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) |
Heteromer | 100 | 2×NGA; | |||
| Crystal structure of Antibody 16A in complex with MUC1 Glycopeptide(GlycoT) |
Heteromer | 100 | 1×NGA; | |||
| Enhanced MHC class I binding and immune responses through anchor modification of the non-canonical … |
Heteromer P01887; Q3UBW0; | 75.0 | 1×NAG; 1×NAG; 2×PO4; 4×MPD; | |||
| Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) |
Heteromer | 100 | 1×NGA; | |||
| Crystal structure of Antibody 16A in complex with MUC1 peptide |
Heteromer | 100 | ||||
| Crystal structure of therapeutic mAB AR20.5 in complex with MUC1 peptide |
Heteromer | 100 | 1×NGA; | |||
| Crystal structure of scFv-SM3 in complex with compound 3 |
Heteromer | 100 | 10×EDO; 1×EEN; | |||
| Crystal structure of scFv-SM3 in complex with compound 2 |
Heteromer | 100 | 8×EDO; 1×EEQ; | |||
| Crystal structure of a MUC1-like glycopeptide containing the unnatural L-4-hydroxynorvaline in comp… |
Heteromer | 83.33 | 6×EDO; 1×A2G; | |||
| Crystal structure of therapeutic mAB AR20.5 in complex with MUC1 peptide |
Heteromer | 100 | ||||
| scFv-1SM3 in complex with glycopeptide containing an sp2-imino sugar |
Heteromer | 100 | 4×EDO; 1×N8W; | |||
| Crystal structure of DmC1GalT1 in complex with UDP-Mn2+ and the APD-TGalNAc-RP |
Heteromer Q7K237; | 100 | 2×UDP; 3×EDO; 2×MN; 2×A2G; | |||
| Crystal structure of the Mucin-1 SEA domain, L1105M mutant, Selenium-derivative | homo-2-mer | 100 | ||||
| Crystal structure of the Mucin-1 SEA domain | homo-2-mer | 100 | ||||
| Solution structure of the SEA domain of human mucin 1 (MUC1) | homo-2-mer | 100 | ||||
3 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7sa9.2.A | monomer | 0.57 | 16.52 | |||
| 9exo.1.A | monomer | 0.55 | 15.52 | |||
| 7dwx.1.D | monomer | 0.51 | 18.45 | |||
18 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 7sa9.2.A | monomer | 0.56 | 16.52 | |||
| Isoform 2 | 7y76.1.E | monomer | 0.52 | 18.45 | |||
| Isoform 2 | 9exo.1.B | monomer | 0.51 | 15.52 | |||
| Isoform 3 | 7sa9.2.A | monomer | 0.57 | 16.52 | |||
| Isoform 3 | 7y76.1.E | monomer | 0.53 | 18.45 | |||
| Isoform 3 | 9exo.1.B | monomer | 0.52 | 15.52 | |||
| Isoform 4 | 7sa9.2.A | monomer | 0.57 | 16.52 | |||
| Isoform 5 | 2acm.1.A | monomer | 0.51 | 87.80 | |||
| Isoform 6 | 8p2x.1.B | monomer | 0.58 | 17.14 | |||
| Isoform 7 | 7sa9.2.A | monomer | 0.56 | 11.11 | |||
| Isoform 8 | 7sa9.1.A | monomer | 0.58 | 15.18 | |||
| Isoform 10 | 8p2x.1.B | monomer | 0.62 | 21.13 | |||
| Isoform 11 | 7sa9.2.A | monomer | 0.55 | 10.78 | |||
| Isoform 12 | 2acm.1.A | monomer | 0.52 | 69.70 | |||
| Isoform 13 | 7sa9.1.A | monomer | 0.58 | 14.81 | |||
| Isoform 15 | 6bsc.1.B | monomer | 0.77 | 100.00 | |||
| Isoform 16 | 8wm3.1.B | monomer | 0.69 | 24.64 | |||
| Isoform 17 | 7sa9.2.A | monomer | 0.56 | 10.78 | |||